Further, CCL2 may be involved in promoting the progression of cognitive impairment through enhancing excitotoxicity, oxidative stress-induced inflammatory damage, and apoptosis in neuronal cells, affecting glutamate metabolism and inducing microglia activation in the local microenvironment (79–82). The gene discussed is CCL2; the disease is Cognitive impairment.